JPS6213931B2 - - Google Patents
Info
- Publication number
- JPS6213931B2 JPS6213931B2 JP56122932A JP12293281A JPS6213931B2 JP S6213931 B2 JPS6213931 B2 JP S6213931B2 JP 56122932 A JP56122932 A JP 56122932A JP 12293281 A JP12293281 A JP 12293281A JP S6213931 B2 JPS6213931 B2 JP S6213931B2
- Authority
- JP
- Japan
- Prior art keywords
- bark
- melium
- methanol
- extraction
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 43
- 239000000284 extract Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000003495 polar organic solvent Substances 0.000 claims description 9
- 229940034982 antineoplastic agent Drugs 0.000 claims description 8
- 239000002246 antineoplastic agent Substances 0.000 claims description 7
- 235000002568 Capsicum frutescens Nutrition 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 2
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 230000009876 antimalignant effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001613 neoplastic effect Effects 0.000 claims 1
- 238000000605 extraction Methods 0.000 description 31
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 20
- 201000011510 cancer Diseases 0.000 description 18
- 206010028980 Neoplasm Diseases 0.000 description 16
- 241000999879 Themelium Species 0.000 description 14
- 239000002032 methanolic fraction Substances 0.000 description 11
- 206010003445 Ascites Diseases 0.000 description 9
- 208000006268 Sarcoma 180 Diseases 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 241000257465 Echinoidea Species 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 230000000118 anti-neoplastic effect Effects 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 241001131796 Botaurus stellaris Species 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 239000002031 ethanolic fraction Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000005534 hematocrit Methods 0.000 description 3
- 239000000401 methanolic extract Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000000233 Melia azedarach Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000227585 Alstonia constricta Species 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 240000000954 Melia azedarach var. toosendan Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000258128 Strongylocentrotus purpuratus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- -1 sorbitan fatty acid ester Chemical class 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56122932A JPS5824523A (ja) | 1981-08-07 | 1981-08-07 | 抗悪性新生物剤 |
| JP61251908A JPS62116521A (ja) | 1981-08-07 | 1986-10-24 | 抗菌剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56122932A JPS5824523A (ja) | 1981-08-07 | 1981-08-07 | 抗悪性新生物剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61251908A Division JPS62116521A (ja) | 1981-08-07 | 1986-10-24 | 抗菌剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5824523A JPS5824523A (ja) | 1983-02-14 |
| JPS6213931B2 true JPS6213931B2 (enrdf_load_stackoverflow) | 1987-03-30 |
Family
ID=14848172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56122932A Granted JPS5824523A (ja) | 1981-08-07 | 1981-08-07 | 抗悪性新生物剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5824523A (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002229074A1 (en) * | 2000-12-15 | 2002-06-24 | Pharmacia Corporation | Selective cox-2 inhibition from plant extracts |
| JP2004256426A (ja) * | 2003-02-25 | 2004-09-16 | Kuniaki Nejime | 抗腫瘍剤 |
-
1981
- 1981-08-07 JP JP56122932A patent/JPS5824523A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5824523A (ja) | 1983-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102114044B (zh) | 一种人工加工熊胆粉及其制备方法 | |
| US4515785A (en) | Neem bark extracts | |
| US4537774A (en) | Hot-water extracts of neem bark | |
| RU2201759C2 (ru) | Фармацевтическая композиция, обладающая противоопухолевой активностью (варианты), и способ ее получения (варианты) | |
| Rates et al. | Chemical constituents and pharmacological activities of Peschiera australis | |
| KR100248942B1 (ko) | 항암 효과를 가지는 삼백초 추출물 및 그의 제조방법 | |
| JPS6213931B2 (enrdf_load_stackoverflow) | ||
| JPH0383929A (ja) | 血糖降下剤 | |
| US3151108A (en) | Kryptoescin and process of making same | |
| US2552896A (en) | Methanol extraction of cascara sagrada bark | |
| JPS6152808B2 (enrdf_load_stackoverflow) | ||
| JPH0120132B2 (enrdf_load_stackoverflow) | ||
| JPS6153334B2 (enrdf_load_stackoverflow) | ||
| JP4480204B2 (ja) | カワリハラタケの抗腫瘍性画分 | |
| JPS6153333B2 (enrdf_load_stackoverflow) | ||
| KR100458003B1 (ko) | 방울비짜루(남옥대)로부터 분리한 신규 항암활성 화합물 및 그 정제방법 | |
| JPS6153335B2 (enrdf_load_stackoverflow) | ||
| JPS63277628A (ja) | 抗腫瘍剤 | |
| JPS6152809B2 (enrdf_load_stackoverflow) | ||
| EP1176149B1 (en) | Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine | |
| FR2481704A1 (fr) | Extrait de plantes du genre epimadium sp procede pour la preparation de cet extrait, agent immunostimulant comprenant cet extrait comme composant actif et immunotherapie obtenue en utilisant cet extrait | |
| CN102961443A (zh) | 北豆根抗肿瘤提取物、制备方法及用途 | |
| JPS6153332B2 (enrdf_load_stackoverflow) | ||
| JPS5935889B2 (ja) | 抗悪性新生物剤 | |
| KR840001510B1 (ko) | 삼지구엽초 sp속 식물로부터의 추출물 제조방법 |